Through
4/30
Penn Medicine and Wistar Receive $12 Million NCI Melanoma Grant to Help Fast Track Lab Discoveries into Treatments
Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE grant from the National Cancer Institute.
Link Between Ritual Circumcision Procedure and Herpes Infection in Infants Examined by Penn Medicine Analysis
A rare procedure occasionally performed during Jewish circumcisions that involves direct oral suction is a likely source of herpes simplex virus type 1 (HSV-1) transmissions documented in infants between 1988 and 2012, a literature review conducted by Penn Medici
Potassium Supplements May Increase Survival in Patients Taking Diuretics for Heart Failure, Penn Study Suggests
Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking prescription potassium supplements together with loop diuretics for heart failure have better survival rates than patients taking diuretics without the potassium. Moreover, the degree of benefit increases with higher diuretic doses.
Major Gaps in Hepatitis C Care Identified As New Drugs and Screening Efforts Emerge, Penn Study Finds
A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.
HIV-infected People with Early-Stage Cancers are up to Four Times More Likely to Go Untreated for Cancer, Penn Study Finds
HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine’s Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.
Penn Medicine: Study Finds 3D Mammography Detects More Invasive Cancers
Reporting in the June 25 issue of JAMA, researchers from Penn Medicine and other institutions found that 3D mammography—known as digital breast tomosynthesis— found significantly more invasive, or potentially lethal, cancers than a traditional mammogram alone and reduced call-backs for additional imaging.
Penn Medicine Researchers Investigate Worry and Behavior Among Teens at Higher Risk for Breast Cancer
Teenage girls with a familial or genetic risk for breast cancer worry more about getting the disease, even when their mother has no history, compared to girls their age with no known high risks, according to new data presented today by researchers from Penn Medicine’s Abramson Cancer Center at the annual
Penn Medicine: Clinical Trials Designed to Block Autophagy in Multiple Cancers Show Promise
In the largest group of results to date, researchers from Penn Medicine’s Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers—glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers—and in some cases helped stabilize disea
Study from Penn Medicine's Abramson Cancer Center Helps Dispel Commonly-Held Beliefs about Cancer Care and Patient Demands for Treatment
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results from a study that will be presented by researchers in the Abramson Cancer Center (ACC) and the Perelman Sch
Penn Medicine: Large Panel Genetic Testing Produces More Questions than Answers in Breast Cancer
While large genetic testing panels promise to uncover clues about patients’ DNA, a team of researchers from Penn Medicine’s Abramson Cancer Center (ACC) has found that those powerful tests tend to produce more questions than they answer.